Tower Research Capital (TRC)’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,444
| Closed | -$1.03K | – | 5285 |
|
2025
Q1 | $1.03K | Sell |
2,444
-18,526
| -88% | -$7.79K | ﹤0.01% | 4782 |
|
2024
Q4 | $14.7K | Buy |
20,970
+9,980
| +91% | +$7K | ﹤0.01% | 3450 |
|
2024
Q3 | $5.15K | Buy |
10,990
+359
| +3% | +$168 | ﹤0.01% | 4320 |
|
2024
Q2 | $17.6K | Buy |
10,631
+4,213
| +66% | +$6.99K | ﹤0.01% | 3827 |
|
2024
Q1 | $11.7K | Buy |
6,418
+1,551
| +32% | +$2.82K | ﹤0.01% | 3542 |
|
2023
Q4 | $9K | Buy |
4,867
+1,308
| +37% | +$2.42K | ﹤0.01% | 4448 |
|
2023
Q3 | $5.13K | Sell |
3,559
-703
| -16% | -$1.01K | ﹤0.01% | 4757 |
|
2023
Q2 | $7.8K | Sell |
4,262
-1,063
| -20% | -$1.95K | ﹤0.01% | 4500 |
|
2023
Q1 | $11K | Buy |
5,325
+1,131
| +27% | +$2.34K | ﹤0.01% | 4190 |
|
2022
Q4 | $9K | Buy |
4,194
+3,257
| +348% | +$6.99K | ﹤0.01% | 4171 |
|
2022
Q3 | $2K | Sell |
937
-970
| -51% | -$2.07K | ﹤0.01% | 5531 |
|
2022
Q2 | $4K | Buy |
+1,907
| New | +$4K | ﹤0.01% | 5178 |
|